Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Primary negative symptoms"'
Autor:
Мосолов, С.Н., Ялтонская, П.А.
Publikováno v:
Современная терапия психических расстройств, Vol 2020, Iss 2 (53), Pp 2-10 (2020)
В статье выполнен обзор актуальных данных литературы (систематические обзоры, мета-анализы), а также приведен алгоритм терапии первично
Externí odkaz:
https://doaj.org/article/be8ed5f6d7564af9807c1b3e4bb3f37a
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2022)
The negative symptoms of schizophrenia include volitional (motivational) impairment manifesting as avolition, anhedonia, social withdrawal, and emotional disorders such as alogia and affective flattening. Negative symptoms worsen patients' quality of
Externí odkaz:
https://doaj.org/article/0ae9ed7fdc194d0881ab930a1947306d
Publikováno v:
European Psychiatry, Vol 64, Pp S50-S50 (2021)
Negative symptoms are considered a core feature of schizophrenia. They are present since the prodromal phase and tend to persist more than other psychopathological dimensions in the chronic stages. The domain of apathy has attracted research efforts
Externí odkaz:
https://doaj.org/article/31c4eaa2f4044c59bd0180404efdab98
Autor:
S. Galderisi, A. Mucci, S. Dollfus, M. Nordentoft, P. Falkai, S. Kaiser, G. M. Giordano, A. Vandevelde, M. Ø. Nielsen, L. B. Glenthøj, M. Sabé, P. Pezzella, I. Bitter, W. Gaebel
Publikováno v:
European Psychiatry, Vol 64 (2021)
AbstractBackgroundDuring the last decades, a renewed interest for negative symptoms (NS) was brought about by the increased awareness that they interfere severely with real-life functioning, particularly when they are primary and persistent.MethodsIn
Externí odkaz:
https://doaj.org/article/c8b2065463924e71bacd42b340c45cb8
Autor:
Areoo Samaei, Amir Ashraf-Ganjouei, Farzin Rezaei, Sayna Bagheri, Rosa Alikhani, Seiedeh Bentolhoda Mousavi, Kamyar Moradi, Shahin Akhondzadeh
Publikováno v:
International Journal of Neuropsychopharmacology
Background Patients with schizophrenia can generally manifest a broad variety of primary negative symptoms. The current study aimed to assess the efficacy and tolerability of resveratrol add-on therapy in the treatment of negative symptoms in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20187337e40c32d88077ffb88a5d43ad
http://europepmc.org/articles/PMC7770519
http://europepmc.org/articles/PMC7770519
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
István Bitter, Giulia Maria Giordano, P. Pezzella, Silvana Galderisi, Mette Ødegaard Nielsen, Wolfgang Gaebel, Michel Sabe, Armida Mucci, Stefan Kaiser, Merete Nordentoft, Louise Birkedal Glenthøj, Sonia Dollfus, A Vandevelde, Peter Falkai
Publikováno v:
European Psychiatry
European Psychiatry, Vol. 64, No 1 (2021) P. e23
Galderisi, S, Mucci, A, Dollfus, S, Nordentoft, M, Falkai, P, Kaiser, S, Giordano, G M, Vandevelde, A, Nielsen, M, Glenthøj, L B, Sabé, M, Pezzella, P, Bitter, I & Gaebel, W 2021, ' EPA guidance on assessment of negative symptoms in schizophrenia ', European psychiatry : the journal of the Association of European Psychiatrists, vol. 64, no. 1, pp. e23 . https://doi.org/10.1192/j.eurpsy.2021.11
European Psychiatry, Vol. 64, No 1 (2021) P. e23
Galderisi, S, Mucci, A, Dollfus, S, Nordentoft, M, Falkai, P, Kaiser, S, Giordano, G M, Vandevelde, A, Nielsen, M, Glenthøj, L B, Sabé, M, Pezzella, P, Bitter, I & Gaebel, W 2021, ' EPA guidance on assessment of negative symptoms in schizophrenia ', European psychiatry : the journal of the Association of European Psychiatrists, vol. 64, no. 1, pp. e23 . https://doi.org/10.1192/j.eurpsy.2021.11
Background During the last decades, a renewed interest for negative symptoms (NS) was brought about by the increased awareness that they interfere severely with real-life functioning, particularly when they are primary and persistent. Methods In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ff7dd08a9f1a166bfbcdfc294f4aaf
https://pubmed.ncbi.nlm.nih.gov/33597064
https://pubmed.ncbi.nlm.nih.gov/33597064
Autor:
Seda Eroglu, Gulser Karakoc, Omer Kitis, Yigit Erdogan, Irmak Polat, Cenan Hepdurgun, Ali Saffet Gonul, Ozgun Ozalay
Although it is generally accepted that negative symptoms of schizophrenia are associated with larger lateral ventricles, this general assumption could not be validated in patients with primary negative symptoms. To elucidate this issue, we conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc72874e5621d25682500e88001b8aae
https://hdl.handle.net/11454/76827
https://hdl.handle.net/11454/76827
Publikováno v:
Experimental and Therapeutic Medicine
The negative symptoms of schizophrenia are an unmet treatment target as currently approved treatments mostly control positive symptoms. The persistence of these symptoms holds back the patient's reinstatement in society, making them incapable of fulf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318a13d1bd9face40116dcedae7bd500
https://pubmed.ncbi.nlm.nih.gov/33603883
https://pubmed.ncbi.nlm.nih.gov/33603883